Stay updated on HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.

Latest updates to the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew site revision entry 'Revision: v3.6.5' added to the history; the previous 'Revision: v3.6.4' entry was removed, reflecting an update to the page's underlying version.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history shows the page updated to revision v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry 'Revision: v3.6.3' is added to the history, while the older 'Revision: v3.6.0' entry is removed. This reflects an update to the page's revision tracking and does not affect the underlying study data or results.SummaryDifference0.1%

- Check66 days agoChange DetectedThe history now shows that the study is no longer looking for participants, indicating that recruitment has ceased. It also records a new revision (v3.6.0) that supersedes the prior revision (v3.5.5).SummaryDifference0.3%

- Check73 days agoChange DetectedThe history shows the record updated to revision v3.5.5, replacing the previous v3.5.4. This reflects a new submission or QC update to the record, not a change to core study details.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the Record History page, signaling a new site release. It does not affect study data or visible trial information.SummaryDifference0.1%

Stay in the know with updates to HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.